Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer

NCT02433639 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02433639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02433639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2015
Completion date
October 31, 2017
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer